NEU 2.13% $15.60 neuren pharmaceuticals limited

Ann: Investor Presentation, 14 March 2023, page-69

  1. 2,021 Posts.
    lightbulb Created with Sketch. 477
    10%jump it gives hope doesn't it? It is probably the greatest outcome of the FDA approval of Daybue for those families living outside the Rett community but inside the very large group of families that survive within the reality of their own particular syndrome. There are mice and then there are humans, to be sure, the quantum comparison stands and is duly acknowledged, but that's where Trofinetide started out - in definitive and compelling mouse models.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.60
Change
-0.340(2.13%)
Mkt cap ! $1.993B
Open High Low Value Volume
$16.25 $16.32 $15.55 $9.440M 595.2K

Buyers (Bids)

No. Vol. Price($)
4 3197 $15.60
 

Sellers (Offers)

Price($) Vol. No.
$15.68 1852 1
View Market Depth
Last trade - 16.10pm 14/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.